Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting cholesterol metabolism in Cancer: From molecular mechanisms to therapeutic implications
Jia Lu, Siwei Chen, Xuejiao Bai, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115907-115907
Closed Access | Times Cited: 17

Showing 17 citing articles:

Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 104
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 12
Recommended and observed statin use among US adults with and without cancer
Ofer Kobo, Erin D. Michos, Ariel Roguin, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 10, pp. 1251-1257
Closed Access | Times Cited: 6
Development of a Prognostic Nomogram Incorporating the Naples Prognostic Score for Postoperative Oral Squamous Cell Carcinoma Patients
Xuelian Xu, Hao Cheng
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 325-345
Open Access
From natural herbal wisdom to nano innovation: Revolutionizing tumor treatment through metabolic reprogramming
Zhengguang Zhang, Haitao Wu, Min Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189263-189263
Closed Access
Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis
Xiaona You, Xi Hu, Zenghui Sun, et al.
Cancer Letters (2025), pp. 217493-217493
Closed Access
Recent Advances in the Development of Sigma Receptor (Radio)Ligands and Their Application in Tumors
Tao Wang, Na Sun, Yuefeng Ma, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 4, pp. 951-977
Closed Access
SQLE—a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration
Yue‐Chen Zhao, Yunfeng Li, Ling Qiu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Targeting piRNA‐137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma
Yuning Zhan, Fanglin Tian, Weina Fan, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
Residual OXPHOS is required to drive primary and metastatic lung tumours in an orthotopic breast cancer model
Patries M. Herst, Georgia Carson, Danielle Lewthwaite, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Novel 18F-Labeled Benzimidazolone-Based Radioligands as Highly Selective Sigma-2 Receptor Probes for Tumor Imaging
Jingqi Wang, Tao Wang, Tiantian Mou, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Evaluating pathological levels of intracellular cholesterol through Raman and surface-enhanced Raman spectroscopies
Enrico Baria, Caterina Dallari, Francesco Mattii, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Repurposing the antipsychotic drug penfluridol for cancer treatment (Review)
Asma Ali Ibrahim Mze, Amirah Abdul Rahman
Oncology Reports (2024) Vol. 52, Iss. 6
Open Access
Research Progress of Lipid Metabolism in Brain Glioma
Qiang Wang
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 147-151
Closed Access
The impact of PTEN status on glioblastoma multiforme: A glial cell type-specific study identifies unique prognostic markers
A.V.S. Sai Krishna, Swati Sinha, Manchanahalli R. Satyanarayana Rao, et al.
Computers in Biology and Medicine (2024) Vol. 184, pp. 109395-109395
Open Access
Cepharanthine as an effective small cell lung cancer inhibitor: integrated insights from network pharmacology, RNA sequencing, and experimental validation
Fengyun Zhao, Zhaowei Ding, Mengting Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
FDFT1 maintains glioblastoma stem cells through activation of the Akt pathway
Hui Mo, Jiajia Shao, Z Y Li, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access
Page 1

Scroll to top